TY - JOUR
T1 - Postoperative speech impairment and cranial nerve deficits in children undergoing posterior fossa tumor surgery with intraoperative MRI – a prospective multinational study
AU - Laustsen, Aske Foldbjerg
AU - Grønbæk, Jonathan Kjær
AU - Frič, Radek
AU - Avula, Shivaram
AU - Mallucci, Conor
AU - Nilsson, Pelle
AU - Nyman, Per
AU - Hauser, Péter
AU - Mudra, Katalin
AU - Kiudeliene, Rosita
AU - Ročka, Saulius
AU - Hjort, Magnus Aasved
AU - Brandsma, Rick
AU - Hoving, Eelco
AU - Carai, Andrea
AU - Beneš, Vladimír
AU - Táborská, Jana
AU - Dorfer, Christian
AU - Jacobs, Sandra
AU - Pavon-Mengual, Miriam
AU - Skjøth-Rasmussen, Jane
AU - Schmiegelow, Kjeld
AU - Sehested, Astrid
AU - Mathiasen, René
AU - Juhler, Marianne
N1 - © 2025. The Author(s).
PY - 2025/9/22
Y1 - 2025/9/22
N2 - BACKGROUND: Postoperative speech impairment (POSI) and cranial nerve deficits (CND) are common complications of pediatric posterior fossa (PF) tumor surgery. Intraoperative MRI (ioMRI) has proven a useful tool in achieving gross total resection. The risk of POSI and CND with ioMRI remains unclear, making it the primary scope of this study. Additionally, we assessed whether POSI was associated with CND.METHODS: We prospectively included pediatric patients undergoing PF tumor surgery in 36 centers across 15 European countries. Neurological status and speech were assessed preoperatively and 1-4 weeks postoperatively. Surgical details, including tumor location and use of ioMRI, were recorded within 72 h of surgery. Postoperative CND were categorized as 0, 1, 2, or ≥ 3 nerves affected; POSI as habitual, reduced speech, or mutism. Proportional odds models estimated odds ratios (OR) for 1) POSI with stepwise adjustment for tumor location and age, and 2) CND with adjustment for preoperative CND and tumor location. Subgroup analyses assessed systematic differences, missing data, center-level effects, and histology adjustment.RESULTS: Of 790 primary PF tumor surgeries, 141 (18%) involved ioMRI. POSI occurred in 183/790 (23%) and postoperative CND in 213/790 (27%). POSI-risk with ioMRI showed non-significant unadjusted OR (95% CI) 0.83 (0.53;1.30); adjusted OR 0.76 (0.43;1.35). Fewer CNDs were observed with ioMRI (unadjusted OR 0.63 (0.40;1.00), adjusted OR 0.58 (0.33;0.94), p = 0.03). POSI-risk was associated with more CNDs (adjusted OR for 1 CND: 2.06 (1.15;3.68); 2 CND: 2.13 (1.02;4.42); ≥ 3 CND: 4.15 (1.98;8.70), p < 0.05).CONCLUSIONS: ioMRI was not associated with increased risk of postoperative complications in this multicenter cohort. The reduction in CND among ioMRI cases may reflect derived effects on surgical decision-making, expertise, case-load and case-mix. Results should be interpreted with caution due to limited intraoperative data. The association between POSI-risk and cumulative CND may indicate extensive brainstem involvement. Our findings highlight the need to further explore how ioMRI-guided strategies affect functional outcomes in pediatric PF tumour surgery.CLINICAL TRIALS ID: NCT02300766 (October 2014).
AB - BACKGROUND: Postoperative speech impairment (POSI) and cranial nerve deficits (CND) are common complications of pediatric posterior fossa (PF) tumor surgery. Intraoperative MRI (ioMRI) has proven a useful tool in achieving gross total resection. The risk of POSI and CND with ioMRI remains unclear, making it the primary scope of this study. Additionally, we assessed whether POSI was associated with CND.METHODS: We prospectively included pediatric patients undergoing PF tumor surgery in 36 centers across 15 European countries. Neurological status and speech were assessed preoperatively and 1-4 weeks postoperatively. Surgical details, including tumor location and use of ioMRI, were recorded within 72 h of surgery. Postoperative CND were categorized as 0, 1, 2, or ≥ 3 nerves affected; POSI as habitual, reduced speech, or mutism. Proportional odds models estimated odds ratios (OR) for 1) POSI with stepwise adjustment for tumor location and age, and 2) CND with adjustment for preoperative CND and tumor location. Subgroup analyses assessed systematic differences, missing data, center-level effects, and histology adjustment.RESULTS: Of 790 primary PF tumor surgeries, 141 (18%) involved ioMRI. POSI occurred in 183/790 (23%) and postoperative CND in 213/790 (27%). POSI-risk with ioMRI showed non-significant unadjusted OR (95% CI) 0.83 (0.53;1.30); adjusted OR 0.76 (0.43;1.35). Fewer CNDs were observed with ioMRI (unadjusted OR 0.63 (0.40;1.00), adjusted OR 0.58 (0.33;0.94), p = 0.03). POSI-risk was associated with more CNDs (adjusted OR for 1 CND: 2.06 (1.15;3.68); 2 CND: 2.13 (1.02;4.42); ≥ 3 CND: 4.15 (1.98;8.70), p < 0.05).CONCLUSIONS: ioMRI was not associated with increased risk of postoperative complications in this multicenter cohort. The reduction in CND among ioMRI cases may reflect derived effects on surgical decision-making, expertise, case-load and case-mix. Results should be interpreted with caution due to limited intraoperative data. The association between POSI-risk and cumulative CND may indicate extensive brainstem involvement. Our findings highlight the need to further explore how ioMRI-guided strategies affect functional outcomes in pediatric PF tumour surgery.CLINICAL TRIALS ID: NCT02300766 (October 2014).
KW - Cerebellar mutism syndrome
KW - Cranial Nerve Deficits
KW - Intraoperative Magnetic Resonance Imaging
KW - Pediatric Neurosurgery
KW - Posterior Fossa Tumor
KW - Posterior Fossa syndrome
KW - Neurosurgical Procedures/adverse effects
KW - Prospective Studies
KW - Speech Disorders/etiology
KW - Cranial Nerve Diseases/etiology
KW - Europe
KW - Humans
KW - Child, Preschool
KW - Infant
KW - Magnetic Resonance Imaging/methods
KW - Male
KW - Infratentorial Neoplasms/surgery
KW - Postoperative Complications/epidemiology
KW - Adolescent
KW - Female
KW - Child
UR - https://www.scopus.com/pages/publications/105016768308
UR - https://www.mendeley.com/catalogue/519ade5c-e76c-3937-a900-0793f5fea132/
U2 - 10.1007/s00701-025-06669-3
DO - 10.1007/s00701-025-06669-3
M3 - Article
C2 - 40982141
AN - SCOPUS:105016768308
SN - 0001-6268
VL - 167
JO - Acta Neurochirurgica
JF - Acta Neurochirurgica
IS - 1
M1 - 252
ER -